Evolving Strategies in the Treatment of Anaemia in Chronic Kidney Disease: The HIF-Prolyl Hydroxylase Inhibitors Francesco LocatelliRoberto MinutoloLucia Del Vecchio Review Article 09 November 2022 Pages: 1565 - 1589
Empagliflozin: A Review in Symptomatic Chronic Heart Failure James E. Frampton Adis Drug Evaluation 14 November 2022 Pages: 1591 - 1602
Darinaparsin: First Approval James E. Frampton AdisInsight Report 04 November 2022 Pages: 1603 - 1609
Correction to: Darinaparsin: First Approval James E. Frampton Correction 14 November 2022 Pages: 1611 - 1611
Valemetostat Tosilate: First Approval Susan J. Keam AdisInsight Report Open access 15 November 2022 Pages: 1621 - 1627